145 related articles for article (PubMed ID: 25542151)
1. Downregulated TIPE2 is associated with poor prognosis and promotes cell proliferation in non-small cell lung cancer.
Li Y; Li X; Liu G; Sun R; Wang L; Wang J; Wang H
Biochem Biophys Res Commun; 2015 Jan; 457(1):43-9. PubMed ID: 25542151
[TBL] [Abstract][Full Text] [Related]
2. TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting Rac1 activation and VEGF expression.
Li Z; Guo C; Liu X; Zhou C; Zhu F; Wang X; Wang Q; Shi Y; Wang J; Zhao W; Zhang L
Oncotarget; 2016 Sep; 7(38):62224-62239. PubMed ID: 27556698
[TBL] [Abstract][Full Text] [Related]
3. TIPE2 Inhibits Lung Cancer Growth Attributing to Promotion of Apoptosis by Regulating Some Apoptotic Molecules Expression.
Liu QQ; Zhang FF; Wang F; Qiu JH; Luo CH; Zhu GY; Liu YF
PLoS One; 2015; 10(5):e0126176. PubMed ID: 25946186
[TBL] [Abstract][Full Text] [Related]
4. TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.
Zhu L; Zhang X; Fu X; Li Z; Sun Z; Wu J; Wang X; Wang F; Li X; Niu S; Ding M; Yang Z; Yang W; Yin M; Zhang L; Zhang M
J Transl Med; 2018 Jan; 16(1):7. PubMed ID: 29343267
[TBL] [Abstract][Full Text] [Related]
5. LRRC3B is downregulated in non-small-cell lung cancer and inhibits cancer cell proliferation and invasion.
Kan L; Li H; Zhang Y; Wang J; Niu H; Jiang H; Zhang M; Bai X; He P
Tumour Biol; 2016 Jan; 37(1):1113-20. PubMed ID: 26276358
[TBL] [Abstract][Full Text] [Related]
6. C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer.
Shi Y; Chen J; Li Z; Zhang Z; Yu H; Sun K; Wang X; Song X; Wang Y; Zhen Y; Yang T; Lou K; Zhang Y; Zhang G; Hu Y; Ji J; Hui R
Oncogene; 2011 Sep; 30(39):4107-17. PubMed ID: 21499297
[TBL] [Abstract][Full Text] [Related]
7. TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location.
Wang G; Guo C; Zhao H; Pan Z; Zhu F; Zhang L; Wang Q
BMC Cancer; 2018 Mar; 18(1):260. PubMed ID: 29510688
[TBL] [Abstract][Full Text] [Related]
8. Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer.
Dong Q; Fu L; Zhao Y; Du Y; Li Q; Qiu X; Wang E
Oncotarget; 2017 Apr; 8(17):27800-27811. PubMed ID: 28468127
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-1290 contributes to cell proliferation and invasion of non small cell lung cancer by targeting interferon regulatory factor 2.
Jin JJ; Liu YH; Si JM; Ni R; Wang J
Int J Biochem Cell Biol; 2018 Feb; 95():113-120. PubMed ID: 29275213
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
[TBL] [Abstract][Full Text] [Related]
12. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
Zheng J; Xu T; Chen F; Zhang Y
Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
[TBL] [Abstract][Full Text] [Related]
13. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer.
Li W; Zheng G; Xia J; Yang G; Sun J; Wang X; Wen M; Sun Y; Zhang Z; Jin F
Cancer Sci; 2018 Apr; 109(4):1012-1023. PubMed ID: 29397041
[TBL] [Abstract][Full Text] [Related]
15. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
[TBL] [Abstract][Full Text] [Related]
16. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
[TBL] [Abstract][Full Text] [Related]
17. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
Yang WB; Zhang WP; Shi JL; Wang JW
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192
[TBL] [Abstract][Full Text] [Related]
18. TRIM31 is downregulated in non-small cell lung cancer and serves as a potential tumor suppressor.
Li H; Zhang Y; Zhang Y; Bai X; Peng Y; He P
Tumour Biol; 2014 Jun; 35(6):5747-52. PubMed ID: 24566900
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.
Li A; Zhang W; Xia H; Miao Y; Zhou H; Zhang X; Dong Q; Li Q; Qiu X; Wang E
Tumour Biol; 2016 Nov; 37(11):15157-15164. PubMed ID: 27677288
[TBL] [Abstract][Full Text] [Related]
20. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
Zhu X; Guo X; Wu S; Wei L
Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
